Chart calendar Altimmune, Inc.

03.YQEr-l7riEIE7RH2agknEByED9t7aC--Xpi0DgcUYNE.KWVEghGf6XZll1KZAGZjdU7dY-01EHfWBNXRYn5nBqsRbGa_NKSlEHa7Yg~9049f6dd3356158f4a6dfb543ac1ceda

Upcoming events on Altimmune, Inc.

2025-03-26 Q4 2024 Earnings Release (Projected)
2025-05-19 Q1 2025 Earnings Release (Projected)
2025-08-06 Q2 2025 Earnings Release (Projected)
2025-11-17 Q3 2025 Earnings Release (Projected)

Past events on Altimmune, Inc.

2024-12-06 09:30 Society on Sarcopenia Cachexia & Wasting Disorders International Conference
2024-12-04 15:30 Piper Sandler Healthcare Conference
2024-12-03 10:50 Evercore ISI HealthCONx Conference
2024-11-15 16:00 American Association for the Study of Liver Disease Meeting
2024-11-13 12:30 UBS Global Healthcare Conference
2024-11-12 08:30 Q3 2024 Earnings Call
2024-11-12 07:00 Q3 2024 Earnings Release
2024-11-11 11:30 Guggenheim Securities Healthcare Innovation Conference
2024-10-07 11:30 H.C. Wainwright MASH Virtual Conference
2024-09-25 Annual General Meeting
2024-09-10 07:45 European Association for the Study of Diabetes Meeting - Session 038, Oral Presentation 557
2024-08-08 08:30 Q2 2024 Earnings Call
2024-08-08 07:00 Q2 2024 Earnings Release
2024-07-08 Leerink Partners Therapeutics I&I and Metabolism Forum
2024-06-26 09:30 Piper Sandler Virtual Obesity Investor Day - Fireside Chat
2024-06-23 13:45 American Diabetes Association Scientific Symposium
2024-06-22 16:45 American Diabetes Association Scientific Symposium
2024-06-12 09:20 Goldman Sachs Global Healthcare Conference - Fireside Chat
2024-06-05 14:00 Jefferies Global Healthcare Conference
2024-06-05 02:30 European Association for the Study of the Liver Congress - Abstract Number: 3002

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million USD
Released
Forecast
Spread
4,41
1,18
274.08%
-0,07
0,05
-241.67%
0,43
0,34
24.04%

0,01


25,0


0,00

EBITDA
Million USD
Released
Forecast
Spread
-96,4
-92,2
-4.51%
-87,9
-89,3
1.53%
-95,5
-83,1
-14.86%

-101


-119


-140

EBIT
Million USD
Released
Forecast
Spread
-85,5
-97,5
12.28%
-87,7
-91,4
3.99%
-83,5
-93,9
11.09%

-104


-109


-180

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-97,1
-99,3
2.24%
-84,9
-91,2
6.88%
-88,4
-81,2
-8.96%

-95,8


-102


-176

Net income
Million USD
Released
Forecast
Spread
-97,1
-98,7
1.64%
-84,7
-90,9
6.82%
-88,4
-81,1
-9.1%

-95,8


-102


-176

EPS
USD
Released
Forecast
Spread
-2,35
-2,41
2.62%
-1,81
-2,04
11.09%
-1,66
-1,47
-13.18%

-1,34


-1,19


-1,69

Announcement Date15/03/2228/02/2327/03/24-

Quarterly results

Fiscal PeriodSeptember 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3
Net sales
Million USD
Released
Forecast
Spread
0,02
0,00
-
0,01
0,00
100%
0,36
0,00
41993.02%
0,04
0,00
1628.97%
0,01
0,00
-
0,01
0,00
706.45%
0,01
0,00
706.45%

0,00


0,00


40,0


0,00


0,00


0,00


0,00


0,00

EBITDA
Million USD
Released
Forecast
Spread
-21,4
-23,9
10.45%
-17,5
-21,7
19.35%
-22,0
-18,1
-21.48%
-31,7
-19,4
-63.57%
-26,7
-21,8
-22.42%
-26,7
-19,9
-34.09%
-24,7
-20,4
-21.23%

-20,9






















EBIT
Million USD
Released
Forecast
Spread
-21,8
-24,8
12.15%
-18,0
-24,3
25.94%
-22,5
-22,6
0.37%
-21,2
-34,9
39.23%
-26,8
-23,7
-13.28%
-26,7
-25,2
-5.99%
-24,8
-26,4
6.03%

-25,3


-31,1


32,7


-38,0


-42,6


-40,3


-42,6


-45,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-20,1
-24,6
18.35%
-16,1
-23,5
31.54%
-20,7
-21,6
4.4%
-31,6
-24,4
-29.94%
-24,4
-22,9
-6.37%
-24,6
-24,2
-1.94%
-22,8
-25,4
10.03%

-24,2


-29,2


34,5


-35,4


-40,4


-38,2


-40,5


-42,9

Net income
Million USD
Released
Forecast
Spread
-20,1
-24,5
18.02%
-16,1
-16,3
1.52%
-20,7
-21,5
3.79%
-31,6
-24,3
-30.25%
-24,4
-22,8
-7.1%
-24,6
-24,8
0.55%
-22,8
-25,7
10.96%

-24,2


-29,2


34,5


-35,4


-40,4


-38,2


-40,5


-42,9

EPS
USD
Released
Forecast
Spread
-0,40
-0,48
16.67%
-0,32
-0,45
29.41%
-0,39
-0,42
6.4%
-0,54
-0,38
-44%
-0,34
-0,36
5.99%
-0,35
-0,35
-1.45%
-0,32
-0,36
10.85%

-0,33


-0,38


0,21


-0,38


-0,42


-0,44


-0,46


-0,48

Announcement Date11/05/2310/08/2307/11/2327/03/2409/05/2408/08/2412/11/24--------

Quarterly revenue - Rate of surprise

quality-estimates-chart ALTIMMUNE-INC

Net sales - Rate of surprise

quality-estimates-chart ALTIMMUNE-INC

Annual profits - Rate of surprise

quality-estimates-chart ALTIMMUNE-INC
  1. Stock Market
  2. Equities
  3. ALT Stock
  4. Calendar Altimmune, Inc.